{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380857597692599552.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Kazutoshi Kaketani"}],"foaf:familyName":[{"@value":"Kaketani"}],"foaf:givenName":[{"@value":"Kazutoshi"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360857597692599552","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.2174/2666958702101010052"},{"@type":"URI","@value":"https://opencovidjournal.com/contents/volumes/V1/TOCOVIDJ-1-52/TOCOVIDJ-1-52.pdf"},{"@type":"URI","@value":"https://opencovidjournal.com/contents/volumes/V1/TOCOVIDJ-1-52/TOCOVIDJ-1-52.xml"}],"notation":[{"@value":"Case Reports: Safety, Tolerability, and Efficacy of 5-Aminolevulinic Acid Phosphate, an Inducer of Heme Oxygenase 1, in Combination with Sodium Ferrous Citrate for the Treatment of COVID-19 Patients"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.2174/2666958702101010052_xU5hld5Kjs0RJ5utcLKuhP30fo"}]}